Cosmetic outcome 1-5 years after breast conservative surgery, irradiation and systemic therapy

Pathology and Oncology Research

Volumn 18, Issue 2, 2012, Pages 421-427

  Kelemen, Gyöngyi ^a   Varga, Zoltán ^a   Lázár, György ^b   Thurzó, László ^a   Kahán, Zsuzsanna ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Breast conserving therapy; Cosmesis; Fibrosis; Irradiated volume; Radiotherapy dose

Indexed keywords

ANASTROZOLE; DOCETAXEL; LETROZOLE; PACLITAXEL; TAMOXIFEN;

ADULT; AGED; ARTICLE; BODY IMAGE; BREAST CANCER; BREAST DISEASE; BREAST EDEMA; BREAST FIBROSIS; CANCER ADJUVANT THERAPY; COMPUTER ASSISTED RADIOTHERAPY; DATA BASE; FEMALE; FOLLOW UP; HUMAN; HYPERPIGMENTATION; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PARTIAL MASTECTOMY; SMOKING; TELANGIECTASIA;

ADULT; AGED; AGED, 80 AND OVER; BODY IMAGE; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; COSMETICS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; PIGMENTATION; PROSPECTIVE STUDIES; RADIOTHERAPY, ADJUVANT; TREATMENT OUTCOME;

EID: 84863424149     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-011-9462-z     Document Type: Article

References (33)

1. Voogd AC, Nielsen M, Peterse JL, Blichert-Toft M, Bartelink H, Overgaard M et al (2001) Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials. J Clin Oncol 19:1688-1697
2. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER et al (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233-1241
3. Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A et al (2002) Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347:1227-1232
4. Offersen BV, Overgaard M, Kroman N, Overgaard J (2009) Accelerated partial breast irradiation as part of breast conserving therapy of early breast carcinoma: a systematic review. Radiother Oncol 90:1-13
5. Fyles AW, McCready DR, Manchul LA, Trudeau ME, Merante P, Pintilie M et al (2004) Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med 351:963-970
6. Fowble B, Fein DA, Hanlon AL, Eisenberg BL, Hoffman JP, Sigurdson ER et al (1996) The impact of tamoxifen on breast recurrence, cosmesis, complications, and survival in estrogen receptor-positive early-stage breast cancer. Int J Radiat Oncol Biol Phys 35:669-677
7. Munshi A, Kakkar S, Bhutani R, Jalali R, Budrukkar A, Dinshaw KA (2009) Factors influencing cosmetic outcome in breast conservation. Clin Oncol (R Coll Radiol) 21:285-293
8. Azria D, Gourgou S, Sozzi WJ, Zouhair A, Mirimanoff RO, Kramar A et al (2004) Concomitant use of tamoxifen with radiotherapy enhances subcutaneous breast fibrosis in hypersensitive patients. Br J Cancer 91:1251-1260
9. Azria D, Betz M, Bourgier C, Sozzi WJ, Ozsahin M (2010) Identifying patients at risk for late radiation-induced toxicity. Crit Rev Oncol Hematol, Epub ahead of print
10. Azria D, Belkacemi Y, Romieu G, Gourgou S, Gutowski M, Zaman K et al (2010) Concurrent or sequential adjuvant letrozole and radiotherapy after conservative surgery for early-stage breast cancer (CO-HO-RT): a phase 2 randomised trial. Lancet Oncol 11:258-265
11. Bartelink H, Horiot JC, Poortmans PM, Struikmans H, Van den Bogaert W, Fourquet A et al (2007) Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol 25:3259-3265
12. Wazer DE, Morr J, Erban JK, Schmid CH, Ruthazer R, Schmidt-Ullrich RK (1997) The effects of postradiation treatment with tamoxifen on local control and cosmetic outcome in the conservatively treated breast. Cancer 80:732-740
13. Collette S, Collette L, Budiharto T, Horiot JC, Poortmans PM, Struikmans H et al (2008) Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer: a study based on the EORTC Trial 22881-10882 'boost versus no boost'. Eur J Cancer 44:2587-2599
14. Taylor ME, Perez CA, Halverson KJ, Kuske RR, Philpott GW, Garcia DM et al (1995) Factors influencing cosmetic results after conservation therapy for breast cancer. Int J Radiat Oncol Biol Phys 31:753-764
15. Johansen J, Overgaard J, Rose C, Engelholm SA, Gadeberg CC, Kjaer M et al (2002) Cosmetic outcome and breast morbidity in breast-conserving treatment - results from the Danish DBCG-82TM national randomized trial in breast cancer. Acta Oncol 41:369-380
16. Curran D, van Dongen JP, Aaronson NK, Kiebert G, Fentiman IS, Mignolet F et al (1998) Quality of life of early-stage breast cancer patients treated with radical mastectomy or breast-conserving procedures: results of EORTC Trial 10801. The European Organization for Research and Treatment of Cancer (EORTC), Breast Cancer Cooperative Group (BCCG). Eur J Cancer 34:307-314
17. Cardoso MJ, Cardoso J, Santos AC, Vrieling C, Christie D, Liljegren G et al (2007) Factors determining esthetic outcome after breast cancer conservative treatment. Breast J 13:140-146
18. Johansen J, Overgaard J, Overgaard M (2007) Effect of adjuvant systemic treatment on cosmetic outcome and late normal-tissue reactions after breast conservation. Acta Oncol 46:525-533
19. Kahan Z, Csenki M, Varga Z, Szil E, Cserhati A, Balogh A et al (2007) The risk of early and late lung sequelae after conformal radiotherapy in breast cancer patients. Int J Radiat Oncol Biol Phys 68:673-681
20. Van Limbergen E, Rijnders A, van der Schueren E, Lerut T, Christiaens R (1989) Cosmetic evaluation of breast conserving treatment for mammary cancer. 2. A quantitative analysis of the influence of radiation dose, fractionation schedules and surgical treatment techniques on cosmetic results. Radiother Oncol 16:253-267
21. Borger JH, Kemperman H, Smitt HS, Hart A, van Dongen J, Lebesque J et al (1994) Dose and volume effects on fibrosis after breast conservation therapy. Int J Radiat Oncol Biol Phys 30:1073-1081
22. Wazer DE, DiPetrillo T, Schmidt-Ullrich R, Weld L, Smith TJ, Marchant DJ et al (1992) Factors influencing cosmetic outcome and complication risk after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol 10:356-363
23. Pezner RD, Patterson MP, Hill LR, Vora NL, Desai KR, Lipsett JA (1985) Breast retraction assessment. Multiple variable analysis of factors responsible for cosmetic retraction in patients treated conservatively for stage I or II breast carcinoma. Acta Radiol Oncol 24:327-330
24. Lilla C, Ambrosone CB, Kropp S, Helmbold I, Schmezer P, von Fournier D et al (2007) Predictive factors for late normal tissue complications following radiotherapy for breast cancer. Breast Cancer Res Treat 106:143-150
25. Porta EA (2002) Pigments in aging: an overview. Ann N Y Acad Sci 959:57-65
26. Moody AM, Mayles WP, Bliss JM, A'Hern RP, Owen JR, Regan J et al (1994) The influence of breast size on late radiation effects and association with radiotherapy dose inhomogeneity. Radiother Oncol 33:106-112
27. Murphy C, Anderson PR, Li T, Bleicher RJ, Sigurdson ER, Goldstein LJ et al (2010) Impact of the radiation boost on outcomes after breast-conserving surgery and radiation. Int J Radiat Oncol Biol Phys Epub ahead of print
28. Ellenbogen R, Jankauskas S, Collini FJ (1990) Achieving standardized photographs in aesthetic surgery. Plast Reconstr Surg 86:955-961
29. Sarin R, Dinshaw KA, Shrivastava SK, Sharma V, Deore SM (1993) Therapeutic factors influencing the cosmetic outcome and late complications in the conservative management of early breast cancer. Int J Radiat Oncol Biol Phys 27:285-292
30. Hill-Kayser CE, Chacko D, Hwang WT, Vapiwala N, Solin LJ (2010) Long-term clinical and cosmetic outcomes after breast conservation treatment for women with early-stage breast carcinoma according to the type of breast boost. Int J Radiat Oncol Biol Phys, Epub ahead of print
31. Harsolia A, Kestin L, Grills I, Wallace M, Jolly S, Jones C et al (2007) Intensity-modulated radiotherapy results in significant decrease in clinical toxicities compared with conventional wedge-based breast radiotherapy. Int J Radiat Oncol Biol Phys 68:1375-1380
32. McDonald MW, Godette KD, Whitaker DJ, Davis LW, Johnstone PA (2010) Three-year outcomes of breast intensity-modulated radiation therapy with simultaneous integrated boost. Int J Radiat Oncol Biol Phys 77:523-530
33. Abner AL, Recht A, Vicini FA, Silver B, Hayes D, Come S et al (1991) Cosmetic results after surgery, chemotherapy, and radiation therapy for early breast cancer. Int J Radiat Oncol Biol Phys 21:331-338